Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Terry Jay Smith, MD
Healthcare Professional Professor
Department of Ophthalmology and Visual Sciences
University of Michigan Kellogg Eye Center
Elevator B Floor 3
1000 Wall St
Ann Arbor, Michigan, United States
Dr. Terry J. Smith, the Frederick G.L. Huetwell Professor in Ophthalmology and Visual Sciences at the University of Michigan, is an internationally-known endocrinologist who has studied Graves’ disease, its eye manifestations, and related autoimmune disease for over 20 years. His areas of practice are Graves’ disease, thyroid-associated ophthalmopathy and metabolic diseases.
Dr. Smith received his medical degree from the University of Missouri School of Medicine and completed his residency at the University of Illinois in Chicago and Sinai Hospital in Baltimore. He has completed fellowships in biophysics at the University of California School of Medicine, San Francisco, in molecular biochemistry at Columbia University in New York, and clinical endocrinology at the Pritzker School of Medicine, University of Chicago.
Dr. Smith is the author of over 150 articles and book chapters, and has been awarded five patents for his research discoveries. He has been elected to the Orbit Society, as chief scientific officer for the National Graves’ Foundation, and serves as reviewer for numerous scientific journals.
Dr. Smith’s research areas are autoimmune thyroid disease, extracellular matrix, cell signaling, gene expression, ecosanoids, inflammation and cytokine action. His laboratory group is interested in understanding and developing new treatments for Graves’ disease (GD) or thyroid-associated ophthalmopathy (TAO).
Representative Publications:
The Insulin-Like Growth Factor-I Receptor and its Role in Thyroid-Associated Ophthalmopathy
Cytokines, Graves’ Disease, and Thyroid-Associated Ophthalmopathy
Related Content
-
Is My Thyroid Condition to Blame for My Hair Loss?Question: Could my thyroid condition be ...
-
Selenium in Graves Hyperthyroidism and OrbitopathyPurpose: To review the in vitro and in ...
-
Thyroglobulin Autoantibodies are Associated With Refractoriness to Antithyroid Drug Treatment for Graves’ Dise...Objective: The recurrence rate associat...
-
Graves’ Disease and PregnancyHypothyroidism During Pregnancy At firs...
-
Lugol’s Solution and Other Iodide Preparations: Perspectives and Research Directions in Graves’ DiseaseLugol's solution and other preparations ...
-
Genetic Predictors of the Development and Recurrence of Graves’ DiseaseGraves' disease affects approximately 3 ...
-
Pulmonary Arterial Hypertension in Patients with Hyperthyroid Graves’ Disease and Toxic Multinodular GoiterA number of case reports and small serie...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.